DUBLIN, Nov. 15, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Medtronic plc MDT recently announced the receipt of the FDA 510 (k) clearance for its PillCam Small Bowel 3 @HOME (SB3) system for remote endoscopy procedures. The latest approval for PillCam further ...

DUBLIN - March 31, 2016 - Medtronic plc (MDT) today announced that the U.S. Food and Drug Administration (FDA) cleared PillCam (TM) COLON 2 capsule for an expanded indication for use. The PillCam (TM) ...

The FDA has cleared Medtronic's ($MDT) PillCam COLON 2 ingestible capsule for an expanded indication in patients who are at major risks for colonoscopy or moderate ...

Medtronic has partnered with the University of Miami Health System to perform the first-ever patient procedure ingestion using the PillCam Genius SB capsule endoscopy kit. The PillCam lets patients ...

PillCam SB3 @HOME offers a telehealth option for direct visualization and monitoring of the small intestine. The Food and Drug Administration (FDA) has cleared the PillCam™ Small Bowel 3 @HOME program ...

Medtronic’s PillCam COLON 2 capsule was cleared by the FDA for an expanded indication. 1. The PillCam COLON 2 capsule is a non-invasive diagnostic test that allows direct visualization of the colon ...

Medtronic plc’s next-generation pill-sized camera saw its first use in a recent appointment, during which it captured thousands of high-definition images of the small bowel mucosa. The company hopes ...

Medtronic secured an FDA clearance for the newest generation of its ingestible digital camera. It will serve as the basis for at-home remote diagnostics programs, which are in high-demand since the ...